Skip to content
  • My Accountmy account
  • Search
FLCCC | Front Line COVID-19 Critical Care Alliance
  • Treatment
    Protocols

    • Protocols

      Read about strategies to prevent and treat conditions like COVID-19, insulin resistance, RSV, long COVID, and more.

      Learn More
      Prevention

      Boost your immune system, clear your body of spike protein, and learn the benefits of intermittent fasting.

      • EAT WELL
      • I-PREVENT Vaccine Injury
      • See all Prevention Protocols
      Treatment

      At-home and hospital treatment plans for COVID, insulin resistance, sepsis, RSV and flu.

      • I-CARE Early At Home Treatment
      • I-CARE RSV and Flu Treatment
      • See all Treatment Protocols
      Recovery

      Approaches to managing symptoms from long COVID and long Vax.

      • I-RECOVER Post Vaccine Treatment
      • I-RECOVER Long Covid
      • See all Recovery Protocols
  • Medical
    Evidence
    • Reviews & Monographs

      In-depth academic pieces presenting original research, analysis, and evidence on complex conditions.

      Cancer Care
    • Studies

      A comprehensive listing of all research, studies, authors and sources cited in each FLCCC prevention and treatment protocol for COVID-19

      Learn More
    • Lectures

      Watch FLCCC doctors speak at international medical conferences, professional seminars and symposiums.

      Learn More
    • Senate Testimony

      Watch Dr. Pierre Kory testify before the U.S. Senate regarding FLCCC protocols to treat COVID-19.

      Learn More
  • COVID
    Resources

    • Wondering where to begin?

      Let us help you find what you’re looking for. We know COVID-19 can be overwhelming; click below to learn more about the resources available to you on this website.

      get started
      Patient Resources
      • Find a Provider
      • Find a Pharmacy
      • Tools & Guides
      • Testimonials
      • Hospital Guide
      Practitioner Resources
      • Efficacy of Ivermectin
      • Informed Consent
      • Nurses for FLCCC
      • Join the Alliance
      • Education on Demand
  • Education &
    Events

    • About the education portal

      FLCCC’s goal is to educate healthcare providers and empower patients with the tools and resources they need to take control of their own health.

      Events

      Our twice-yearly conferences bring top experts from a variety of fields together to learn, share, and network with each other.

      • Learn More
      Education on Demand

      Stream video lectures, download slide presentations, and get exclusive access to key facts, data, and references from FLCCC educational programs.

      • My Content
      • Explore Courses
  • News &
    Webinars
    • Latest Updates

      Stay up-to-date with the latest news from our fast-moving field.

      View
    • Blog

      Subscribe to our blog to read our weekly news capsule and be the first to receive the latest announcements from FLCCC.

      Read Now
    • Weekly Webinars

      Sign up for our webinars, every Wednesday at 7pm ET, offering the latest information on therapeutics and treatments and answering audience questions.

      Learn More
    • FLCCC in the News

      Read media coverage of FLCCC from around the world.

      View
  • About
    FLCCC

    • About the FLCCC

      Learn about the history of FLCCC, our mission and vision, and how you can get involved.

      learn more
      • Our Physicians
      • Our Partners
      • Advocacy
      • FAQ
      • Terms and Conditions
      • Impact Reports
      • Annual Reports
      • Support Us
      • Shop our Store
      • Connect with Us
  • Donate
  • Treatment Protocols
  • Find a Provider
  • Find a Pharmacy
  • Medical Evidence
    • Cancer Care
    • Studies
    • Lectures
    • Senate Testimony
  • COVID Resources
    • Get Started
    • Tools & Guides
    • Ivermectin
    • Hospital Guide
    • Nurses for FLCCC
    • Join The Alliance
  • Education & Events
    • Educational Conference
    • Education on Demand
    • My Content
  • News & Webinars
    • Latest Updates
    • FLCCC Blog
    • Weekly Webinars
    • FLCCC in the News
  • About The FLCCC
  • FAQ
  • Connect with Us
  • Donate
  • Cart
FLCCC | Front Line COVID-19 Critical Care Alliance
  • Treatment Protocols
  • Find a Provider
  • Find a Pharmacy
  • Medical Evidence
    • Cancer Care
    • Studies
    • Lectures
    • Senate Testimony
  • COVID Resources
    • Get Started
    • Tools & Guides
    • Ivermectin
    • Hospital Guide
    • Nurses for FLCCC
    • Join The Alliance
  • Education & Events
    • Educational Conference
    • Education on Demand
    • My Content
  • News & Webinars
    • Latest Updates
    • FLCCC Blog
    • Weekly Webinars
    • FLCCC in the News
  • About The FLCCC
  • FAQ
  • Connect with Us
  • Donate
  • Cart
Donate

References

Categories

I-CARE Early Covid (187) I-CARE Flu and RSV (36) I-PREVENT (153) I-RECOVER Long Covid (111) I-RECOVER Post-Vaccine (320) MATH+ (171)

Tags

ACE2 protein (10) acute respiratory distress syndrome (13) Alopecia (7) Anti-inflammatory (8) Antidepressants (9) Ascorbic Acid (9) autoantibodies (10) autophagy (24) Calcifediol (6) Cancer (9) Corticosteroids (8) COVID-19 (255) COVID-19 Vaccines (8) Curcumin (8) Cytokines (10) Depression (10) Famotidine (14) flavonoids (5) Glucocorticoids (6) Hydroxychloroquine (12) Hyperbaric Oxygen Therapy (9) Inflammation (14) ivermectin (46) long COVID (21) Mast Cells (8) Melatonin (20) molnupiravir (5) N-Acetylcysteine (6) Non-Invasive Brain Stimulation (8) Omicron (7) Oxytocin (8) Pneumonia (8) quercetin (15) resveratrol (5) SARS-CoV-2 (72) SARS-CoV-2 mRNA Vaccines (7) Sepsis (15) spermidine (11) Spike Protein (10) Thrombosis (9) Tinnitus (12) Valproic Acid (5) Vitamin C (16) Vitamin D (9) Zinc (12)
  • Reference: Symptoms persisting after hospitalization for COVID-19: 12 month interim results of the COFLOW study.

    Published On: October 24, 2022

    Authors: Bek LM, Berentschot JC, Huijts S, Vlake JH, Aerts JG PMID: 36284829 PMCID: PMC9421428 DOI: 10.1183/23120541.00355-2022 Abstract Introduction: A large proportion of patients experience a wide range of sequelae after acute COVID-19, especially after severe illness. The long-term health sequelae need to be assessed. Our objective was to longitudinally assess [...]

    Categories: I-RECOVER Long Covid

    Tags: COVID-19, long COVID, symptoms

  • Reference: Androgen receptor inhibition alleviated inflammation in experimental autoimmune myocarditis by increasing autophagy in macrophages.

    Published On: May 25, 2022

    Authors: Ma WH, Zhang XG, Guo LL, Zhang JB, Wei FT PMID: 34109585 DOI: 10.26355/eurrev_202105_25944 Abstract Objective: Experimental autoimmune myocarditis (EAM) is characterized by pronounced macrophage infiltration, cardiac necrosis, and cardiac fibrosis. Our previous studies have demonstrated that suppressed androgen receptor (AR) enables anti-inflammation to promote tissue repair by decreasing M1 macrophages and increasing M2 [...]

    Categories: I-RECOVER Long Covid

    Tags: autophagy

  • Reference: A raising dawn of pentoxifylline in the management of inflammatory disorders in Covid-19.

    Published On: April 29, 2022

    Authors: Mostafa-Hedeab G, Al-kuraishy HM, Al-Gareeb AA, Jeandet P, Saaad HM, El-Saber Batiha G PMID: 35486310 PMCID: PMC9051499 DOI: 10.1007/s10787-022-00993-1 Abstract The existing pandemic viral infection caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) leads to coronavirus disease 2019 (Covid-19). SARS-CoV-2 exploits angiotensin-converting enzyme 2 (ACE2) as an entry-point into affected cells and [...]

    Categories: I-RECOVER Long Covid, I-RECOVER Post-Vaccine

    Tags: COVID-19, Pentoxifylline

  • Reference: Long COVID neuropsychological deficits after severe, moderate or mild infection.

    Published On: March 29, 2022

    Authors: Voruz P, Allali G, Benzakour L, Jacot I, Pierce J doi: https://doi.org/10.3390/ctn6020009 Abstract There is growing awareness that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, even in its mild or moderate respiratory forms, can include long-term neuropsychological deficits. Standardized neuropsychological, psychiatric, neurological, and olfactory tests were administered to 45 patients 236.51 ± 22.54 [...]

    Categories: I-RECOVER Long Covid

    Tags: long COVID, neuropsychological

  • Reference: Autoantibodies targeting GPCRs and RAS-related molecules associated with COVID-19 severity.

    Published On: March 9, 2022

    Authors: Cabral-Marques O, Halpert G, Schimke LF, Ostrinski Y, Vojdani A, Lattin MT PMID: 35264564 PMCID: PMC8907309 DOI: 10.1038/s41467-022-28905-5 Abstract COVID-19 shares the feature of autoantibody production with systemic autoimmune diseases. In order to understand the role of these immune globulins in the pathogenesis of the disease, it is important to explore the autoantibody spectra. [...]

    Categories: I-RECOVER Long Covid, I-RECOVER Post-Vaccine

    Tags: autoantibodies, COVID-19

  • Reference: The neuroprotective effects of intermittent fasting on brain aging and neurodegenerative diseases via regulating mitochondrial function.

    Published On: February 24, 2022

    Authors: Zhao Y, Jia M, Chen W, Liu Z PMID: 35218914 DOI: 10.1016/j.freeradbiomed.2022.02.021 Abstract Intermittent fasting (IF) has been studied for its effects on lifespan and the prevention or delay of age-related diseases upon the regulation of metabolic pathways. Mitochondria participate in key metabolic pathways and play important roles in maintaining intracellular signaling networks that [...]

    Categories: I-RECOVER Long Covid, I-RECOVER Post-Vaccine

    Tags: intermittent fasting

  • Reference: High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (COLDSTER).

    Published On: February 17, 2022

    Authors: Dhooria S, Chaudhary S, Sehgal IS, Agarwal R, Arora S PMID: 34887325 PMCID: PMC8850687 DOI: 10.1183/13993003.02930-2021 Abstract High-dose prednisolone may not be superior to a low-dose 6-week regimen in improving clinical, physiological and radiological outcomes, or health-related quality of life, in patients with symptomatic post-COVID-19 diffuse parenchymal lung abnormalities. Keywords: prednisolone, Long COVID, COVID-19 [...]

    Categories: I-RECOVER Long Covid

    Tags: Prednisone

  • Reference: Use of N-Acetylcysteine at high doses as an oral treatment for patients with COVID-19.

    Published On: January 10, 2022

    Authors: Izquierdo JL, Soriano JB, Gonzalez Y, Lumbreras S PMID: 35084258 PMCID: PMC8795755 DOI: 10.1177/00368504221074574 Abstract Infection by SARS-CoV-2 causing coronavirus disease 2019 (COVID-19) can be associated with serious and life-threatening conditions, including acute respiratory distress syndrome (ARDS). Severity and mortality have been related to a cytokine storm, an imbalance of oxidative stress, and a [...]

    Categories: I-CARE Early Covid, I-RECOVER Long Covid, I-RECOVER Post-Vaccine, MATH+

    Tags: COVID-19, N-Acetylcysteine

  • Reference: Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection.

    Published On: January 10, 2022

    Authors: Patterson BK, Francisco EB, Yogendra R, Long E, Pise A, Hall E et al. PMID: 35082777 PMCID: PMC8784688 DOI: 10.3389/fimmu.2021.746021 AbstractThe recent COVID-19 pandemic is a treatment challenge in the acute infection stage but the recognition of chronic COVID-19 symptoms termed post-acute sequelae SARS-CoV-2 infection (PASC) may affect up to 30% of all infected [...]

    Categories: I-RECOVER Long Covid, I-RECOVER Post-Vaccine

    Tags: COVID-19

  • Reference: Characterising long-term covid-19: a rapid living systematic review.

    Published On: September 6, 2021

    Authors:Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens D, Hastie C. . PMID: PMC8478580 DOI: 10.1136/bmjgh-2021-005427 Abstract Background: While it is now apparent clinical sequelae (long COVID) may persist after acute COVID-19, their nature, frequency and aetiology are poorly characterised. This study aims to regularly synthesise evidence on long COVID characteristics, to help inform [...]

    Categories: I-RECOVER Long Covid

    Tags: COVID-19, long COVID

12Next
FLCCC Logo with white letters
Support Us

We are a 100% donor-supported 501(c)(3) non-profit organization. Our work would not be possible without you! Help us expand our reach and share life-saving research.

Give Now
shop
Contact Us
Mailing Address

FLCCC Alliance
2001 L St. NW Suite 500
Washington, DC 20036

Media

[email protected]

Clinical Support

[email protected]

General

[email protected]

Shortcuts
  • About the FLCCC